You are here:

levetiracetam (Keppra®) 100mg oral solution


Following an abbreviated submission

Levetiracetam 100 mg/ml oral solution is accepted for restricted use in NHS Scotland as an additional dosage form for adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in patients for whom therapy is appropriate. Its use should be initiated by physicians who have appropriate experience in the treatment of epilepsy. The budget impact for NHS Scotland is likely to be small.

Drug Details

Drug Name: levetiracetam (Keppra®) 100mg oral solution
SMC Drug ID: 151/04
Manufacturer: UCB Pharma Ltd
Indication: Epilepsy
BNF Category:
Sub Category: 4.8 Antiepileptic drugs
Submission Type: Abbreviated Submission
Status: Restricted
Date Advice Published: 10 January 2005